Results from a US actual use trial conducted by PEGUS to evaluate consumer adherence to dosing directions for a 400 mg OTC pain reliever were recently published in the International Journal of Clinical Pharmacology and Therapeutics. Clark Richardson, PEGUS Senior Consultant for the project, was one of the authors, together with authors from the study sponsor, Pfizer Consumer Healthcare.
We are pleased to have another example of prescription-to-over-the-counter switch research published in the literature and hope it can help contribute to the overall body of knowledge regarding best OTC research practices and critical consumer product use behavior dynamics.
For additional information, please see the abstract here.
